Long-term effects of consumption of a novel fat emulsion in relation to body-weight management

Int J Obes (Lond). 2007 Jun;31(6):942-9. doi: 10.1038/sj.ijo.0803532. Epub 2007 Feb 13.

Abstract

Objective: To assess weight maintenance after weight loss by consumption of yoghurt with a novel fat emulsion (Olibra) including effects on body composition, resting energy expenditure (REE), fat oxidation, hunger feelings and satiety hormones.

Design: A randomized, placebo-controlled, double-blind, parallel design. A 6-week weight loss period (2.1 MJ/day) was followed by 18 weeks weight maintenance with test (Olibra) or placebo yoghurt.

Subjects: Fifty overweight women (age: 18-58 years, body mass index (BMI) 25-32 kg/m2).

Measurements: In weeks 1, 7 and 25, a satiety test with questionnaires and blood samples for analysis of satiety hormones. In weeks 2, 8 and 26, REE, body weight and body composition.

Results: During weight maintenance after significant body weight reduction, there was no significant increase in body weight in the test group (1.1+/-3.4 kg); the placebo group did gain weight (3.0+/-3.1 kg, P<0.001). Compared to the placebo group, the test group was less hungry 4 h after yoghurt consumption in week 25 (P<0.05) and showed increased glucagon like peptide-1 values 180 min after yoghurt consumption (week 25 vs week 1, P<0.05). Measured REE as a function of fat-free mass (FFM) was significantly higher than predicted REE (P<0.05) in week 26 for the test group, but not for the placebo group. Fat mass (FM) was significantly more decreased in the test group (6.5+/-4.1 kg) compared to the placebo group (4.1+/-3.6 kg) (week 26 vs week 2, P<0.05).

Conclusion: Consumption of Olibra yoghurt improved weight maintenance compared to placebo, which can be explained by the relatively higher REE as a function of FFM, relatively higher decrease in FM and the relatively lower increase in hunger.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Appetite Depressants / therapeutic use*
  • Body Mass Index
  • Body Weight / physiology*
  • Caloric Restriction / methods
  • Cholecystokinin / blood
  • Dietary Supplements*
  • Double-Blind Method
  • Emulsions
  • Energy Metabolism / physiology
  • Fats*
  • Female
  • Ghrelin
  • Glucagon-Like Peptide 1 / blood
  • Humans
  • Hunger / physiology
  • Middle Aged
  • Obesity / diet therapy
  • Overweight / physiology*
  • Peptide Hormones / blood
  • Satiety Response / physiology
  • Weight Gain / physiology
  • Weight Loss / physiology
  • Yogurt

Substances

  • Appetite Depressants
  • Emulsions
  • Fats
  • Ghrelin
  • Peptide Hormones
  • Glucagon-Like Peptide 1
  • Cholecystokinin